MCL1 and pancreatic neoplasm: MCL1, which is a target of FBXW7 and a member of the BCL2 protein family, is an anti-apoptotic protein that has been reported to be overexpressed in pancreatic cancer cells and clinical tissue samples and is correlated with advanced disease [15].